Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
61.21 Down 0.16(0.26%) 2:29PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:61.37
Open:61.40
Bid:61.25 x 400
Ask:61.28 x 100
1y Target Est:84.26
Beta:0.54
Next Earnings Date: 1-May-14BMRN Earnings announcement
Day's Range:60.50 - 62.61
52wk Range:53.53 - 84.25
Volume:1,104,569
Avg Vol (3m):1,612,400
Market Cap:8.79B
P/E (ttm):N/A
EPS (ttm):-1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
BMRNDown 0.26%8.79B
FOLDUp 1.10%114.56M
SHPGUp 0.06%27.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.81
Quarterly EPS Est (Mar-14) :-0.45
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback